検診

Question

PubMed検索式(((("Breast Neoplasms/diagnosis"[MAJR]) AND (("Sensitivity andSpecificity"[MeSH]) OR ("Survival Rate"[MeSH]))) AND ("ultrasonography,mammary"[MeSH Terms]OR ultrasound OR ultrasonic OR ultrasonogr*)) AND

CQ1

Hand-held（用手的）超音波検査は乳がん検診として推奨されるか？

(screen*[Title])) OR (((((handheld[Title/Abstract]) OR ("hand held"[Title/Abstract]
OR HHUS)) AND (breast)) AND (screen*[Title])) AND ("ultrasonography,mammary"[MeSH Terms]OR ultrasound OR ultrasonic OR ultrasonogr*)) Filters:English, Japanese, from 1000/1/1 - 2021/3/31(((("Breast Density"[Mesh] OR "mammographic density" OR "mammographicdensities" OR "mammographic breast density" OR "mammographic breast

FRQ1

マンモグラフィの乳房構成の判定に自動測定ソフトを用いることは有用か？

densities") AND ("mammography"[MeSH Terms])) AND (((automated OR automatic)
OR ("deep learning"[All Fields])) OR ("computer assisted"[All Fields] OR "computeraided"[All Fields]))) AND (english[Filter] OR japanese[Filter])) AND(1000/01/01:2021/03/31[Date - Publication])((("mammography"[MeSH Terms]) AND ((((("artificial intelligence"[MeSH Terms])

マンモグラフィ乳がん検診において読影AIソフトウェアを併用することは有FRQ2用か？

OR ("artificial intelligence"[All Fields])) OR ("machine learning"[All Fields])) OR("deep learning"[All Fields])) OR ("computer aided"[All Fields]))) AND((("screening"[All Fields]) OR ("surveillance"[All Fields])) OR ("detection"[AllFields]))) AND (english[Filter] OR japanese[Filter]) Filters: from 2016/1/1 2021/3/31(((((((BRCA*[Text Word]) OR ("hereditary breast"[Text Word])) OR((((((heredit*[Title/Abstract]) OR (inherit*[Title/Abstract])) OR(genet*[Title/Abstract])) OR (familial*[Title/Abstract])) OR (mutat*[Title/Abstract]))
OR (ethnolog*[Title/Abstract]))) AND (("breast cancer"[Title/Abstract]) OR ("breastCQ2BRCA病的バリアント保持者に対する乳癌サーベイランスには造影乳房MRIneoplasms"[MeSH Terms]))) AND (("diagnostic imaging"[MeSH Terms]) ORが推奨されるか？

("diagnostic imaging"[MeSH Subheading]))) AND (((surveillance[Title/Abstract]) OR(screening[Title/Abstract])) OR (early diagnosis[MeSH Terms]))) AND ((("sensitivityand specificity"[MeSH Terms]) OR (sensitiv*[Title/Abstract])) OR (risk[TextWord]))) AND (2016/01/01:2021/03/31[Date - Publication] AND("english"[Language] OR "japanese"[Language]))CQ3

診断マンモグラフィにおいて乳房トモシンセシスを追加することは推奨されるか？

(breast neoplasms/diagnosis[MeSH] AND "mammography"[MeSH] AND
tomosynthesis[ti]) AND (1000/1/1:2021/3/31[pdat]) AND (english[Filter] ORjapanese[Filter])(((("calcinosis"[MeSH Terms]) OR (calcification*)) AND (breastFRQ3マンモグラフィ検診の淡い集簇石灰化病変にマンモグラフィガイド下生検は neoplasms/diagnosis[MeSH Terms])) AND (mammography[MeSH Terms])) AND
必須か？

(risk) AND (english[Filter] OR japanese[Filter]) AND (1000/01/01:2021/03/31[Date- Publication])

画像診断

Question

PubMed検索式((Breast neoplasms[Mesh]) AND ("Elasticity Imaging Techniques"[Mesh] OR
Elastography[tiab] OR Elasticity[MH] OR Elasticity[tiab] OR sonoelastograph*[TIAB]
OR RTE[tiab] OR strain[tiab] OR shear wave[tiab] OR rigidity[tiab] OR RTE[tiab] OR

CQ4

乳房腫瘤の精密検査として乳房超音波エラストグラフィは推奨されるか？

Virtual touch imaging[tiab] OR Virtual Touch Image Quantification[tiab] ORVTQ[tiab] OR VTI[tiab] OR SWE[tiab] OR "Artifacts"[Mesh])) AND(Diagnosis[subheading] OR Diagnostic imaging[subheading]) AND(1000/01/01:2021/03/31[DP])FRQ4

乳房腫瘤の精密検査としてドプラ法を用いた非造影超音波検査による血流評
価は有用か？

("Breast Neoplasms"[Mesh]) AND ("Ultrasonography, Mammary"[Mesh] OR"Ultrasonography, Doppler"[Mesh]) AND (flow[tiab] OR Color[tiab] OR Colour[tiab]
OR Power[tiab] OR Vasculari*)(((Breast Neoplasms[Mesh]) AND (Contrast Media[Mesh] OR "contrast

CQ5

乳房病変の良悪性鑑別目的に造影超音波検査は勧められるか？

enhanced"[tiab] OR CEUS[tiab])) AND (Ultrasonography[Mesh] OR
Ultrasound[tiab]))(2010/01/01[dp]:2021/03/31[dp]) AND (("Breast/diagnostic imaging"[Mesh] OR

BQ1

術前造影乳房MRIで新たに検出される病変（MRI-detected lesion)に対する精査は必要か？

"Breast Neoplasms/diagnostic imaging"[Mesh] OR "Breast/diagnosis"[Mesh] OR"Breast Neoplasms/diagnosis"[Mesh]) AND (("Magnetic ResonanceImaging"[Mesh] OR MRI[tiab] OR magnetic resonance imaging[tiab]) AND
detected[TIAB]))((((Breast neoplasms[Mesh] OR Breast cancer[Tiab]) AND (("NeoplasmStaging"[Mesh] OR staging[TIAB] OR staging[TIAB] or early stage[TIAB] orprimary[tiab]))) AND ("Tomography, X-Ray Computed"[Mesh] OR "PositronBQ2

StageⅠ-Ⅱ乳癌の術前にCT,PET,PET-CTによる全身検索を行うか？

Emission Tomography"[Mesh] OR "Positron Emission Tomography Computed
Tomography"[Mesh] OR PET[TIAB] OR CT[TIAB] OR Computed tomography[TIAB]OR PETCT[TIAB])) AND ((sensitiv*[TIAB] OR sensitivity and specificity[MeSH] OR(predictive[TIAB] AND value*[TIAB]) OR predictive value of tests[MeSH] OR
accuracy*[TIAB]))) AND ((2016/01/01[dp]:2021/03/31[dp]))((((Breast neoplasms[Mesh] OR Breast cancer[tiab] OR Breast[tiab]) AND(("Neoadjuvant Therapy"[Mesh] OR preoperative chemotherapy[TIAB] ORNeoadjuvant chemotherapy[TIAB]）)) AND (("Tomography, X-Ray Computed"[Mesh]
OR "Positron-Emission Tomography"[Mesh] OR "Positron Emission Tomography

FRQ5

術前化学療法後の病理学的完全奏効(pCR)予測に術前MRIまたはPETは有用

Computed Tomography"[Mesh] OR PET[TIAB] OR CT[TIAB] OR Computedか？

tomography[TIAB] OR PETCT[TIAB] OR Magnetic Resonance Imaging[Mesh] OR

術前化学療法における早期効果予測（治療前・中間評価）にMRIまたはPET MRI[Tiab] OR Ultrasonography[Mesh] OR Ultrasound[tiab] ORは有用か？

"Mammography"[Mesh] OR mammography[tiab] OR "Ultrasonography,Mammary"[Mesh]))) AND ("Remission Induction"[Mesh] OR Pathological Complete
Response[tiab] OR Pathologic complete response[tiab] OR Pathologicalresponse[tiab] OR pathologically comfirmed[tiab] OR Predict[tiab] OR pCR[Tiab]))AND (1000/01/01:2021/03/31[dp])(("Breast Neoplasms"[Mesh] OR "Breast"[Mesh]) AND ((dedicated[tiab] OR highresolution[tiab] OR ring[tiab]) AND (("Tomography, X-Ray Computed"[Mesh] OR"Positron-Emission Tomography"[Mesh] OR "Positron Emission Tomography

FRQ6乳房専用PETは乳癌術前の広がり診断に有用か？

Computed Tomography"[Mesh] OR PET[TIAB] OR CT[TIAB] OR Computedtomography[TIAB] OR PETCT[TIAB] OR PEM[TIAB] OR Positron Emission
Mammography[TIAB] OR Breast-Specific PET[TIAB] OR Mammo PET[TIAB]))))AND (1000/01/01:2021/03/31[dp])(((("Breast Neoplasms"[Mesh]) AND ((Mammography[Mesh] AND (Contrast
Media[Mesh] OR Contrast enhanced[tiab])) OR Contrast enhanced spectral
mammography[Tiab] OR Contrast enhanced digital mammography[Tiab] OR
CEDM[Tiab] OR CESM[Tiab])) AND ("Diagnosis"[Mesh] OR"Diagnosis"[Subheading] OR "diagnostic imaging" [Subheading] OR "Diagnostic
FRQ7

造影マンモグラフィは乳癌術前の広がり診断に有用か？

Imaging"[Mesh])) AND ("Neoplasm Recurrence, Local"[Mesh] OR recurren*[TIAB]
OR "False Positive Reactions"[Mesh] OR "false positive"[TIAB] OR
contralateral*[TIAB] OR "Neoplasm Invasiveness"[Mesh] OR extent*[TIAB] OR"Preoperative Period"[Mesh] OR "Preoperative Care"[Mesh] OR preoperat*[TIAB]
OR pre-operat*[TIAB] OR pre-surgical[TIAB] OR "Neoplasm Staging"[Mesh] ORstaging[TIAB])) AND (1000/01/01:2021/3/31[dp])((((Breast Neoplasms[Mesh] OR Breast Cancer[tiab]) AND (Neoplasm Recurrence,Local[Mesh] OR Neoplasms, Second primary[Mesh] OR Recurrence[tiab])) AND

FRQ8

乳房全切除後の対側乳房や、乳房部分切除術後の温存乳房に、超音波検査や造影乳房MRIを定期的に行うか？

(("follow-up studies"[mesh] or follow-up[tiab] or surveillance[tiab] orprognosis[mesh] OR routine[tiab] or constant[tiab] or always[tiab] or ever[tiab])))AND (((Magnetic Resonance Imaging[Mesh] OR MRI[Tiab]) AND (ContrastMedia[Mesh] OR "contrast enhanced"[tiab])) OR ((Ultrasonography[Mesh] ORUltrasound[tiab])))) AND ((1000/01/01[dp]:2021/03/31[dp]))((("Breast Neoplasms"[Mesh] OR Breast cancer[tiab]) AND ("follow-upFRQ9StageⅠ-Ⅱ乳癌術後の定期的な前進画像検査は勧められるか？

studies"[mesh] or follow-up[tiab] or surveillance[tiab] or prognosis[mesh] ORroutine[tiab] or constant[tiab] or always[tiab] or ever[tiab])) AND ("Whole Body
Imaging"[Mesh] OR intensive[tiab])) AND ((0000/01/01[dp]:2021/03/31[dp]))